Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00789113 · ClinicalTrials.gov registry record · Phase 1
Determination of Absorption and Elimination of Lamotrigine-XR
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00789113 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 12 participants.
The verdict
NCT00789113, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
People over 65 years of ag break down (metabolize) drugs differently than younger adults. It is not known why this happens or how elderly people absorb or break down these drug differently. These difference may show that elderly individuals need lower doses of medications to avoid possible toxicity. We are interested in studying how yor body absorbs and breaks down your lamotrigine medication. This research may indicate that doses of lamotrigine should be lowered as people get older.
Interventions
- DRUG Extended Release Lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00789113
The ClinicalTrials.gov registry entry for NCT00789113 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Extended Release Lamotrigine is the first listed.
NCT00789113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00789113 about?
NCT00789113 is a clinical study titled "Determination of Absorption and Elimination of Lamotrigine-XR". People over 65 years of ag break down (metabolize) drugs differently than younger adults. It is not known why this happens or how elderly people absorb or break down these drug differently. These difference may show that elderly individuals need lower doses of medications to avoid possible toxicity....
What is the current status of trial NCT00789113?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2008-11. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00789113?
The interventions under investigation include: Extended Release Lamotrigine (DRUG).
Who is sponsoring clinical trial NCT00789113?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.